|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
Join us for the first in a series of webinars highlighting the groundbreaking testing offered by CellTrend Laboratory in Germany. Emerging research is uncovering the role of a novel class of biomarkers: autoantibodies, which are antibodies that mistakenly target the body’s own receptors in complex neuroimmune and autonomic disorders such as Myalgic Encephalomyelitis (M.E.), Postural Orthostatic Tachycardia Syndrome (POTS), Small
Free
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
DISCLAIMER: THIS SITE DOES NOT PROVIDE MEDICAL ADVICE
The information on these webpages and AONM webinars is intended for educational and informative purposes only and is not intended as a substitute for medical or professional advice, diagnosis or treatment. Always seek the advice of your doctor or other qualified health care provider with regards to any questions you may have regarding a medical condition or treatment before undertaking a health care regimen. Never disregard or delay seeking professional medical advice because of information you have read or seen on this website. AONM may assist and guide patients and practitioners with regards to which tests are appropriate to take, but any tests taken through AONM do not constitute a medical diagnosis on the part of AONM. AONM makes no claims whatsoever to be able to diagnose medical conditions but to provide tests which can help to form the basis of a diagnosis on the part of qualified practitioners.